Clinical Trial

Vascular Intervention Strategies Trial for Alzheimer's

Study acronym: VISTA
Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The proposed pharmacist-led study is a feasibility pilot trial for the management of vascular risk factors of hypertension and hypercholesterolemia in 10 APOE ε4 carriers, 50-75, at-risk for dementia. All participants will receive angiotensin receptor blockers (ARBs) for high blood pressure, and hydrophilic statins (or a non-statin alternative) for high cholesterol over a six-month period.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2026-02-25; most recent amendment 2026-04-27.
Trial Details
NCT Number NCT07447206
Lead Sponsor University of Southern California
Conditions Hypertension, Hypercholesterolemia, Dementia Risk Factors
Enrollment 10 participants
Start Date 2026-05
Primary Completion 2027-06 (estimated)
Study Completion 2028-06 (estimated)
Updated on ClinicalTrials.gov 2026-05-04